Edesa Biotech Inc (NASDAQ:EDSA)
| 5.72 Delayed Data As of Jan 22 |  +0.59 / +11.50%Today’s Change | 1.58 Today|||52-Week Range 19.10 | +34.59% Year-to-Date |
Latest EDSA News | Press Releases
No recent news for Edesa Biotech Inc.
Today’s Trading
| Previous close | 5.13 |
| Today’s open | 5.34 |
| Day’s range | 5.34 - 5.90 |
| Volume | 1,931 |
| Average volume (3 months) | 167,767 |
| Market cap | $54.2M |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | -0.58% |
| Earnings growth (this year) | -27.70% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -39.98% |
| P/E ratio | NM |
| Price/Sales | 211.25 |
| Price/Book | 7.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NAVBNavidea Biopharmaceu... | +0.04 | +1.78% |
| ARPOAerpio Pharmaceutica... | -0.03 | -2.29% |
| PDSBPDS Biotechnology Co... | +0.09 | +3.26% |
| ---- |
Data as of 4:47pm ET, 01/22/2021
Financials
| Next reporting date | February 18, 2021 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $328.8K |
| Annual profit (last year) | -$6.4M |
| Net profit margin | -1,935.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Markham, Ontario |
Forecasts
